Clin2
NCT07516496Likely a fitRecruiting

Understanding Body Chemistry in Vascular Ehlers-Danlos Syndrome

Vascular Ehlers-Danlos SyndromeVascular Ehlers Danlos SyndromeVascular EDS (vEDS)

Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Hormones & metabolism, Skin clinical trials.

This study looks at how bodies with vascular Ehlers-Danlos syndrome (vEDS) process nutrients and energy differently. By comparing people with vEDS to healthy volunteers, researchers hope to find new ways to manage the condition better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
15 people
Ages
18 years to 85 years
Study type
Observational

Who can take part

  • You must be 18 years old or older
  • You must have a confirmed genetic mutation in COL3A1 that causes vascular Ehlers-Danlos syndrome
  • You must be able to understand the study and give your permission to participate
  • You cannot be taking corticosteroid medications (like prednisone) right now
  • You cannot be pregnant or breastfeeding
  • You cannot be acutely ill or recovering from a recent infection when you join

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07697573Not yet recruiting
Exercise and lifestyle program for vascular Ehlers-Danlos syndrome

This study tests whether a supervised exercise and lifestyle program is safe and feasible for adults with vascular Ehlers-Danlos syndrome (vEDS). You will follow a gentle activity plan designed for your condition, and researchers will track your health and well-being over time.

Sheffield, South Yorkshire
NCT05994664Recruiting
Heart Coherence Training for Vascular Ehlers-Danlos

This study tests whether a breathing and heart-rate training program (called Heart Coherence Training) can help people with Vascular Ehlers-Danlos syndrome feel better. It's done from home using your phone and a computer or tablet.

Houston, Texas
NCT05432466Recruiting· Phase 3
Celiprolol vs placebo for vascular Ehlers-Danlos heart vessel fragility

This Phase 3 study compares celiprolol (a blood vessel–related medicine) versus placebo to see which better reduces vascular risks in people with vascular Ehlers-Danlos syndrome. It requires confirmed COL3A1 genetic findings and specific imaging before starting.

Culver City, California
NCT06336473Not yet recruiting
Does cross-linking improve skin strength in Ehlers-Danlos syndrome?

This study tests whether a chemical cross-linking treatment can change the stretchiness and strength of skin in people with classic or hypermobile Ehlers-Danlos syndrome. Small skin samples will be taken to study the effects in the lab.

Paris
NCT07151274Recruiting
Ehlers-Danlos syndrome and women's gynecological health

This study uses an online questionnaire to explore how Ehlers-Danlos syndrome (EDS) may affect gynecological health. It compares women with EDS to those without, to better understand any differences.

Rouen
NCT04310644Recruiting
Study of nerve and connective-tissue symptoms in EDS and autonomic issues

This study collects information about how the body’s automatic nerves (autonomic nerves) affect symptoms like fast heart rate on standing, fatigue, and related conditions in people with Ehlers-Danlos syndrome. It also enrolls healthy volunteers to compare results, which may help doctors understand these conditions better and improve care.

Aachen, North Rhine-Westphalia

Hear when a new Vascular Ehlers-Danlos Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.